Health Canada authorizes mRNA vaccine trial for Ebola virus causing huge outbreak in Congo

Canada is now the second country to authorize a Phase I clinical trial for a Bundibugyo virus vaccine candidate after the U.K., according to federal officials in a news release.

Health Canada has given Moderna the green light to launch a clinical trial for a vaccine targeting the Bundibugyo form of the Ebola virus, which continues to surge throughout the Democratic Republic of the Congo.